Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Evidence for a role of macrophage migration inhibitory factor in vascular disease.

Chen Z, Sakuma M, Zago AC, Zhang X, Shi C, Leng L, Mizue Y, Bucala R, Simon D.

Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):709-14. Epub 2004 Jan 29.

2.

Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice.

Pan JH, Sukhova GK, Yang JT, Wang B, Xie T, Fu H, Zhang Y, Satoskar AR, David JR, Metz CN, Bucala R, Fang K, Simon DI, Chapman HA, Libby P, Shi GP.

Circulation. 2004 Jun 29;109(25):3149-53. Epub 2004 Jun 14.

3.

Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids.

Chen Z, Fukutomi T, Zago AC, Ehlers R, Detmers PA, Wright SD, Rogers C, Simon DI.

Circulation. 2002 Jul 2;106(1):20-3.

4.

Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice.

Schober A, Bernhagen J, Thiele M, Zeiffer U, Knarren S, Roller M, Bucala R, Weber C.

Circulation. 2004 Jan 27;109(3):380-5. Epub 2003 Dec 22.

5.

Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice.

Chadjichristos CE, Matter CM, Roth I, Sutter E, Pelli G, Lüscher TF, Chanson M, Kwak BR.

Circulation. 2006 Jun 20;113(24):2835-43. Epub 2006 Jun 12.

6.

Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation.

Matter CM, Chadjichristos CE, Meier P, von Lukowicz T, Lohmann C, Schuler PK, Zhang D, Odermatt B, Hofmann E, Brunner T, Kwak BR, Lüscher TF.

Circulation. 2006 Apr 18;113(15):1879-87. Epub 2006 Apr 10.

7.

Interleukin-18 and macrophage migration inhibitory factor are associated with increased carotid intima-media thickening.

Korshunov VA, Nikonenko TA, Tkachuk VA, Brooks A, Berk BC.

Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):295-300. Epub 2005 Nov 17.

8.

C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.

Shagdarsuren E, Bidzhekov K, Mause SF, Simsekyilmaz S, Polakowski T, Hawlisch H, Gessner JE, Zernecke A, Weber C.

Circulation. 2010 Sep 7;122(10):1026-36. doi: 10.1161/CIRCULATIONAHA.110.954370. Epub 2010 Aug 23.

9.

Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.

Francis DJ, Parish CR, McGarry M, Santiago FS, Lowe HC, Brown KJ, Bingley JA, Hayward IP, Cowden WB, Campbell JH, Campbell GR, Chesterman CN, Khachigian LM.

Circ Res. 2003 May 2;92(8):e70-7. Epub 2003 Apr 10.

10.

Platelet, not endothelial, P-selectin is required for neointimal formation after vascular injury.

Wang K, Zhou X, Zhou Z, Mal N, Fan L, Zhang M, Lincoff AM, Plow EF, Topol EJ, Penn MS.

Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1584-9. Epub 2005 Jun 9.

11.

Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.

Schober A, Zernecke A, Liehn EA, von Hundelshausen P, Knarren S, Kuziel WA, Weber C.

Circ Res. 2004 Nov 26;95(11):1125-33. Epub 2004 Nov 4.

12.

Altered vascular injury responses in mice deficient in protease-activated receptor-1.

Cheung WM, D'Andrea MR, Andrade-Gordon P, Damiano BP.

Arterioscler Thromb Vasc Biol. 1999 Dec;19(12):3014-24.

13.

Beta3-integrin mediates smooth muscle cell accumulation in neointima after carotid ligation in mice.

Choi ET, Khan MF, Leidenfrost JE, Collins ET, Boc KP, Villa BR, Novack DV, Parks WC, Abendschein DR.

Circulation. 2004 Mar 30;109(12):1564-9. Epub 2004 Mar 8.

14.

Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor.

George J, Sack J, Barshack I, Keren P, Goldberg I, Haklai R, Elad-Sfadia G, Kloog Y, Keren G.

Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):363-8. Epub 2003 Dec 11.

15.

Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury.

Maffia P, Grassia G, Di Meglio P, Carnuccio R, Berrino L, Garside P, Ianaro A, Ialenti A.

Circulation. 2006 Aug 1;114(5):430-7. Epub 2006 Jul 24.

16.

Vascular remodeling and mobilization of bone marrow-derived cells in cuff-induced vascular injury in LDL receptor knockout mice.

Xu Y, Arai H, Murayama T, Kita T, Yokode M.

Chin Med J (Engl). 2008 Feb 5;121(3):220-6.

PMID:
18298913
18.

Role of histamine H1 and H2 receptor antagonists in the prevention of intimal thickening.

Miyazawa N, Watanabe S, Matsuda A, Kondo K, Hashimoto H, Umemura K, Nakashima M.

Eur J Pharmacol. 1998 Nov 27;362(1):53-9.

PMID:
9865530
19.

Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model.

Hinagata J, Kakutani M, Fujii T, Naruko T, Inoue N, Fujita Y, Mehta JL, Ueda M, Sawamura T.

Cardiovasc Res. 2006 Jan;69(1):263-71. Epub 2005 Sep 22.

PMID:
16183045
20.

Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis.

Sanz-González SM, Barquín L, García-Cao I, Roque M, González JM, Fuster JJ, Castells MT, Flores JM, Serrano M, Andrés V.

Cardiovasc Res. 2007 Sep 1;75(4):803-12. Epub 2007 May 10.

PMID:
17570351

Supplemental Content

Support Center